Home » EVOTEC, ROCHE FORM ALLIANCE TO JOINTLY DISCOVER NEW DRUGS
EVOTEC, ROCHE FORM ALLIANCE TO JOINTLY DISCOVER NEW DRUGS
Swiss drugmaker Roche and German drugmaker Evotec have formed an alliance to jointly discover and develop compounds against a target for central nervous system (CNS) diseases and other indications, the companies announced.
The companies will collaborate to identify inhibitors involved in the potential treatment of a range of diseases.
"We have been working with Roche for many years in an atmosphere of mutual respect -- in service agreements and in-licensing of CNS drugs -- and are looking forward to now partnering one of our CNS discovery projects into this joint effort," said John Kemp, executive vice president for research and development at Evotec.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May